Update: Ukrainian company Darnitsa signs sublicence agreement with MPP bringing to 36 the number of generic manufacturers to produce generic versions of Pfizer's oral COVID-19 treatment - MPP
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Stock Photo - Image of medical, gastroesophageal: 187163353
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
UPDATED: AstraZeneca and Sanofi tweak stances on Russian operations as pharma contends with war in Ukraine | Fierce Pharma
An IGI Series on Global Responsibilities: "The Global Impacts of The War in Ukraine" (2023) | Illinois Global Institute at Illinois
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva Pharmaceutical Industries Ltd. - Ukrainian Prime Minister Volodymyr Groysman visited Teva's production plant in Jerusalem today, leading a delegation of ministers and senior officials and as part of an official visit
KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy
Change at the top at Teva as Vigodman departs - PMLiVE
$519 million FCPA Payment by Teva Pharmaceuticals—Largest Ever FCPA Payment by Pharmaceutical Company—Follows Large FCPA Ple
Teva bribery settlement raises questions on Argentina, Romania probes | The Times of Israel
Yossi Ofek - VP, Cluster Head of Middle East, Africa & Ukraine | General Manager at Teva Israel - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceutical Industries — Вікіпедія
Teva to pay $519 million for paying bribes in Russia, Ukraine, and Mexico
Pharmaceutical industry response to the war in Ukraine
Teva announces $519 million FCPA settlement | The FCPA Blog
Teva's Cephalon to ink $65.8M class-action settlement in Provigil pay-for-delay suit after judge's OK | Fierce Pharma